Sydney researchers have successfully grown tissue from all known types of endometriosis. 

The achievement opens up new avenues for research into more effective treatments and targeted diagnoses for the debilitating condition. 

Endometriosis affects approximately one in nine women and can manifest in various ways, typically including severe and debilitating pain. 

By growing 30 different lab-grown tissues taken during surgery, the researchers at Sydney's Royal Hospital for Women can now test drugs and match patients' symptoms with specific proteins. 

The breakthrough should enable accurate diagnoses and potentially reduce the need for invasive surgeries.

Professor Jason Abbott, the hospital's expert in obstetrics and gynaecology, compared the complexity of endometriosis to breast cancer.

He says that different types of endometriosis likely reflect different diseases with varying responses to treatment, symptoms, and fertility implications. The ability to test drugs on lab-grown tissues will expedite the development of new treatments.

Endometriosis has a significant impact on women's working lives, with recent studies revealing that women with endometriosis are twice as likely to require 10 or more sick days per year and reported diminished work quality. 

Endometriosis Australia estimates that the illness costs the country $9.7 billion annually, with $2.5 billion spent on direct healthcare costs and the remainder on lost productivity.